NEW DELHI – The United States has denied and revoked visas for several Indian business executives and corporate leaders accused of trafficking fentanyl precursors, a move the U.S. Embassy in New Delhi described as part of its tougher stance against the global drug trade. Close family members of those individuals may also be barred from traveling to the U.S., signaling a sharper enforcement approach that American officials said was both necessary and overdue.Travel guides
The embassy confirmed that executives linked to companies involved in trafficking fentanyl precursors will now face additional scrutiny in the visa process. “The U.S. Embassy in New Delhi remains steadfast in its commitment to combating illicit drug trafficking,” Chargé d’affaires Jorgan Andrews said. “Individuals and organizations involved in the illegal production and trafficking of drugs to the United States, along with their families, will face consequences that may include being denied access to the United States.”
Officials framed the action as part of a broader campaign to confront the deadly fentanyl crisis, which continues to claim tens of thousands of lives each year in the U.S. The embassy said its efforts are not only punitive but also cooperative, highlighting the role of bilateral collaboration in addressing the problem. “Stopping the flow of fentanyl, including its precursors, to the United States is one of our top priorities. We are grateful to our counterparts in the Government of India for their close cooperation to combat this shared challenge,” it said.
The statement noted that the Trump administration has already acted through Executive Orders to secure U.S. borders, dismantle trafficking networks, and press source countries for reforms. Building on those measures, embassy officials stressed that only joint efforts between India and the U.S. can address what they called a transnational threat.Bollywood movies
“Together, we will build a safer, healthier, stronger future for America and India,” the embassy concluded.